We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46 | -0.93% | 49.00 | 49.00 | 49.95 | 49.595 | 48.97 | 49.48 | 1,113,911 | 01:00:00 |
From May 2019 to May 2024
By Chris Wack
Synthorx Inc. (THOR) shares were up 165% to $66.28 premarket after Sanofi SA (SAN.FR) said it was buying the clinical-stage biotechnology for $68 a share in cash.
The deal has an equity value of about $2.5 billion, and is expected to close in the first quarter of next year.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 09, 2019 07:08 ET (12:08 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
